← Open Payments lookup

RACHEL LUBER: Open Payments

NPI 1376106807 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$814 in 43 payments from 19 companies in 2025. Trend: 2023 $883 · 2024 $598 · 2025 $814

Food & beverage: $814
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.5$120
ANI Pharmaceuticals, Inc.5$109
Vifor Pharma, Inc.4$66
Novo Nordisk Inc3$65
Travere Therapeutics, Inc.7$64
Bayer Healthcare Pharmaceuticals Inc.3$54
Novartis Pharmaceuticals Corporation2$48
Otsuka America Pharmaceutical, Inc.2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Mallinckrodt Hospital Products Inc.1$28

Products named: TARPEYO, PURIFIED CORTROPHIN GEL, Veltassa, Ozempic, Kerendia, Vanrafia, JYNARQUE, JARDIANCE.

Industry payments across MO — which companies pay providers there.